VONAGE HOLDINGS CORP 4
4 · VONAGE HOLDINGS CORP · Filed Feb 19, 2015
Insider Transaction Report
Form 4
Tempora Michael A.
SVP, Program Mgmt.
Transactions
- Sale
Common Stock
2015-02-17$4.41/sh−11,960$52,732→ 0 total - Exercise/Conversion
Common Stock
2015-02-17$1.37/sh+11,960$16,385→ 11,960 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-02-17−11,960→ 61,918 totalExercise: $1.37Exp: 2020-04-01→ Common Stock (11,960 underlying)
Footnotes (3)
- [F1]Sale was made pursuant to a trading plan under Rule 10b5-1 under the Securities and Exchange Act of 1934, as amended, which was adopted on August 6, 2014 for estate planning and diversification purposes.
- [F2]The price reported in Column 4 is a weighted average price. The Common Stock was sold at prices ranging from $4.33 to $4.45. Upon request, the Reporting Person will provide to the Securities and Exchange Commission staff, the Issuer and any security holder of the Issuer full information regarding the number of shares of Common Stock sold at each separate price within the range.
- [F3]The option, originally representing a right to purchase a total of 195,510 shares, vested in equal annual installments over a period of four years beginning on April 1, 2010.